While overstimulation by CD3 bispecific antibodies might deplete all tumor-resident T cells, we show here that CD8+ T-cell reduction following repeated TTS injections is limited to Vβ3 TTS-reactive T cells. The gene discussed is CD8A; the disease is neoplasm.